Tempest Therapeutics TPST
NASDAQ TPST
$0.81 -0.10 (-11.07%)
As of: Sep 10, 2026 · 3:52 PM EDT

Tempest Therapeutics (TPST) Gross Margin (QoQ) (2015 - 2018)

Analysis

Tempest Therapeutics (TPST) Gross Margin (QoQ) (2015 - 2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Krystal Biotech 10.26 Bn 9.41 Bn 112.79 Mn
2 CRISPR Therapeutics AG 5.04 Bn 5.04 Bn -
3 Iovance Biotherapeutics 3.66 Bn 3.36 Bn 55.72 Mn
4 Legend Biotech 3.55 Bn 2.58 Bn 251.50 Mn
5 uniQure 2.95 Bn 2.95 Bn 5.49 Mn
6 Beam Therapeutics 2.54 Bn 2.54 Bn -
7 Precigen 2.38 Bn 2.38 Bn 52.17 Mn
8 Sarepta Therapeutics 2.16 Bn 1.37 Bn 251.87 Mn
9 Vericel 1.93 Bn 1.77 Bn 56.40 Mn
10 Tempest Therapeutics 3.35 Mn 2.55 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 -1,333.00
Jun 30, 2018 10,050.00
Mar 31, 2018 7,240.00
Dec 31, 2017 -18,777.00
Sep 30, 2017 27,440.00
Jun 30, 2017 10,079.00
Mar 31, 2017 75,731.00
Dec 31, 2016 -39,293.00
Sep 30, 2016 -13,899.00
Jun 30, 2016 15,310.00
Mar 31, 2016 -6,790.00
Dec 31, 2015 51,575.00
Sep 30, 2015 -86,667.00
Jun 30, 2015 -15,333.00